Clinical trial
Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer…
NCT00399945 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00399945 |
|---|---|
| Title | Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study |
| Official title | A Phase 1, Single-Dose, Open-Label, Two-Way Crossover, Pharmacoscintigraphy Study of Aerosol Delivery Characteristics (Measured by In Vivo Lung Deposition, Nebulization Time, Serum Tobramycin Concentrations, and Pharmacokinetic Parameters) and Safety of Tobramycin Administered for Inhalation by PARI… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | Tobramycin |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| First posted | Nov 15, 2006 |
| Last update posted | May 7, 2007 |
| Countries | United Kingdom |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: